DGAP-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): Issue of Debt/Financing
SHOP APOTHEKE EUROPE announces result of convertible bond placement.

14.01.2021 / 15:42
The issuer is solely responsible for the content of this announcement.


For further information, please follow the link: 

https://shop-apotheke-europe.com/en/investorrelations/restricted/convertible-bonds_2021-01.html
 


14.01.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: SHOP APOTHEKE EUROPE N.V.
Dirk Hartogweg 14
5928 LV Venlo
Netherlands
Phone: 0800 - 200 800 300
Fax: 0800 - 90 70 90 20
E-mail: carmen.herkenrath@shop-apotheke.com
Internet: www.shop-apotheke-europe.com
ISIN: NL0012044747, DE000A19Y072
WKN: A2AR94, A19Y07
Indices: MDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1160695

 
End of News DGAP News Service

1160695  14.01.2021 

fncls.ssp?fn=show_t_gif&application_id=1160695&application_name=news&site_id=zonebourse_sftp